I

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Cell Therapy Account Management

Account ManagementConfirmed live in the last 24 hours
Full-time$200k - $220k /yr

About the Job

Requirements

  • 8–12 years of related experience with a bachelor’s degree, or 6 years of experience with a master’s degree, or a PhD with 3 years of experience, or equivalent experience in a similar role within oncology, cell therapy, or rare disease.
  • Use strategic foresight to optimize strategy and build service lines at academic hospitals.
  • Demonstrate deep market knowledge of oncology and immunotherapy, including reimbursement and policy landscapes within academic hospitals, oncology clinics, and extensive community practices.
  • Have prior experience with products and therapies requiring complex delivery systems, including logistics management and regulatory and compliance requirements such as Good Manufacturing Practice and quality systems.
  • Be able to coach and drive alignment with field-based and internal cross-functional partners.
  • Use data analytics to optimize decision-making and planning around Amtagvi’s uptake strategy.
  • Demonstrate initiative, urgency, and perseverance in a fast-paced, entrepreneurial environment.
  • Have a valid driver’s license.
  • Remain stationary, standing or sitting, for prolonged periods; move about inside an office and exert up to 10 pounds of force occasionally or negligible force frequently or constantly; have visual acuity for preparing and analyzing data and figures, viewing a computer screen, and reading extensively; perform repetitive wrist, hand, and/or finger motions; and communicate with others to exchange information.
  • Apply clear and conceptual thinking, judgment, troubleshooting, problem-solving, analysis, and discretion; handle work-related stress, multiple priorities, and deadlines.

Responsibilities

  • Drive Amtagvi demand and appropriate pull-through at targeted authorized treatment centers, and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives.
  • Serve as the primary commercial point of contact for the Iovance iPOD at authorized treatment centers offering commercially available Amtagvi, and lead development and onboarding of new TIL service lines at target centers.
  • Educate site personnel on clinical and product information for Amtagvi.
  • Provide knowledge and expertise about Iovance products and processes to service-line customer stakeholders.
  • Collaborate with authorized treatment center operations to align cell therapy logistics, processes, and operations.
  • Build business relationships with clinical thought leaders, Amtagvi prescribers, and institutional stakeholders to influence uptake and provide customer service.
  • Develop and maintain knowledge of the disease state, Amtagvi, and the competitive landscape.
  • Attend and support regional and national professional meetings and congresses.
  • Facilitate engagement with key thought leaders, cell therapy prescribers, and institutional stakeholders.
  • Collaborate with cross-functional partners in market access, operations, quality, marketing, and medical teams to support patient identification, Amtagvi infusion, and related clinical care.
  • Provide timely feedback to Iovance management about account business trends, therapeutic landscape changes, industry issues, and business opportunities.
  • Collaborate with sales leadership to develop and implement strategic account plans for qualified academic institutions and large community medical oncology practices.
  • Maintain compliance with U.S. and global healthcare laws and regulations.
  • Exemplify Iovance’s core values, policies, procedures, and business ethics.
  • Perform other duties as assigned.
  • Travel 50%.

Desired Qualifications

  • Oncology, cell therapy, or rare disease experience.
  • An MBA or other related graduate-level degree.
  • New product launch experience.
  • Experience in oncology care, new product launches, and cell therapy.

About the Company

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Iovance Biotherapeutics develops cancer immunotherapies using Tumor Infiltrating Lymphocytes (TIL). It harvests T cells from a patient’s tumor, expands them in the lab, and infuses them back into the patient to attack solid tumors. The therapies are designed as single-treatment treatments without the need for ongoing maintenance. The company differentiates itself by focusing on TIL-based adoptive cell therapy with broad antigen targeting and dedicated cell therapy manufacturing capabilities, including the Iovance Cell Therapy Center (iCTC) to scale production. Its goal is to develop, manufacture, and commercialize proprietary TIL therapies and expand access to cell-based cancer treatments through partnerships and scaled production.

Company size
501-1,000
Company stage
IPO
Headquarters
San Carlos, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Iovance Biotherapeutics

See more jobs